Patents by Inventor György Rabloczky

György Rabloczky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synergistic pharmaceutical combination for the prevention or treatment of diabetes
    Patent number: 8048873
    Abstract: The invention refers to a synergistic pharmaceutical combination which comprises (a) a first pharmaceutical composition containing an antidiabetic or anti-hyperlipidemic active agent and one or more conventional carrier(s), and (b) a second pharmaceutical composition containing a hydroximic acid derivative of the formula I and one or more conventional carrier(s). The pharmaceutical combination is suitable for the prevention or treatment of, among others, diabetes mellitus.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: November 1, 2011
    Assignee: N-Gene Research Laboratories, Inc.
    Inventors: Zoltán Szilvássy, György Rabloczky, András Rabloczky, legal representative, Péter Literáti Nagy
  • SYNERGISTIC PHARMACEUTICAL COMBINATION FOR THE PREVENTION OR TREATMENT OF DIABETES
    Publication number: 20100048627
    Abstract: The invention refers to a synergistic pharmaceutical combination which comprises (a) a first pharmaceutical composition containing an antidiabetic or anti-hyperlipidemic active agent and one or more conventional carrier(s), and (b) a second pharmaceutical composition containing a hydroximic acid derivative of the formula I and one or more conventional carrier(s). The pharmaceutical combination is suitable for the prevention or treatment of, among others, diabetes mellitus.
    Type: Application
    Filed: November 6, 2009
    Publication date: February 25, 2010
    Inventors: Zoltan SZILVASSY, György RABLOCZKY, Péter LITERÁTI NAGY, András RABLOCZKY
  • Synergistic pharmaceutical combination for the prevention or treatment of diabetes
    Patent number: 7635674
    Abstract: The invention refers to a synergistic pharmaceutical combination which comprises (a) a first pharmaceutical composition containing an antidiabetic or anti-hyperlipidemic active agent and one or more conventional carrier(s), and (b) a second pharmaceutical composition containing a hydroximic acid derivative of the formula I and one or more conventional carrier(s). The pharmaceutical combination is suitable for the prevention or treatment of, among others, diabetes mellitus.
    Type: Grant
    Filed: July 10, 2002
    Date of Patent: December 22, 2009
    Assignee: N-Gene Research Laboratories, Inc.
    Inventors: Zoltán Szilvássy, György Rabloczky, András Rabloczky, legal representative, Péter Literáti Nagy
  • N-([1,4]benzodioxan-2-ylmethyl)-N-(3-chloro-1-propyl)-amine
    Patent number: 6248907
    Abstract: The invention relates to R-2-[3-([1,4]benzodioxan-2-ylmethylamino)-1-propyl]-3(2H)-pyridazinone of formula (1), and to S-2-[3-([1,4]benzodioxan-2-ylmethylamino)-1-propyl]-3(2H)-pyridazinone of formula (2), and to acid-addition salts thereof as well as pharmaceutical compositions containing these compounds. Furthermore, the invention relates to a process for the preparation of the above compounds. The new starting compounds of formulae (4) and (5) are also involved in the scope of the invention. The compounds according to the invention possess &agr;1- and &agr;2-adrenoceptor antagonistic effects and urogenital selectivity. Thus, they are useful for the treatment of the benign prostate hyperplasia.
    Type: Grant
    Filed: August 28, 2000
    Date of Patent: June 19, 2001
    Assignee: Gyogyszerkutato Intezet Kft.
    Inventors: Péter Mátyus, László Hársing, Marianne Tapfer née Karim, Judit Kosáry, Ágnes Papp née Behr, Antal Simay, Yemane Tilahun, Éva Tomori née Joszt, Edit Horváth, Katalin Horváth, Ildikó Varga, Erzsébet Zára née Kaczián, Margit Bidló née Iglóy, Alice Druga, György Rabloczky, Márta Varga, Egon Kárpáti, Endre Kasztreiner, István Király, Ildikó Máthé née Gyóry, György Máthé, László Sebestyén, Nándor Makk
  • 3(2H)-pyridazinone derivatives and pharmaceutical compositions containing these compounds
    Patent number: 6194411
    Abstract: The invention relates to R-2-[3-([1,4]benzodioxan-2-ylmethylamino)-1-propyl]-3(2H)-pyridazionone of formula (1) and to S-2-[3-([1,4]benzodioxan-2-ylmethylamino)-1-propyl]-3(2H)-pyridazionone of formula (2) and to acid-addition salts thereof as well as pharmaceutical compositions containing these compounds. Furthermore, the invention relates to a process for the preparation of the above compounds. The new starting compounds of formula (4) and (5) are also involved in the scope of the invention. The compounds according to the invention possess &agr;1- and &agr;2-adrenoceptor antagonistic effects and urogenital selectivity. Thus, they are useful for the treatment of the benign prostate hyperplasia.
    Type: Grant
    Filed: July 20, 1998
    Date of Patent: February 27, 2001
    Assignee: Gyogyszerkutato Intezet Kft.
    Inventors: Péter Mátyus, László Hársing, Mariann née Tapfer Karim, Judit Kosáry, Ágnes née Behr Papp, Antal Simay, Yemane Tilahun, Éva née Joszt Tomori, Edit Horváth, Katalin Horváth, Ildikó Varga, Erzsébet née Kaczián Zára, Margit née Iglóy Bidló, Alice Druga, György Rabloczky, Márta Varga, Egon Kárpáti, Endre Kasztreiner, István Király, Ildikó née Gyóry Máthé, György Máthé, László Sebestyén, Nándor Makk